eCTD Submissions of IND/NDA to the US FDA, EU and Canada 2018

eCTD Submissions of IND/NDA to the US FDA, EU and Canada 2018

 

  • Until March 10 Early Bird Price

    Sale Date Ended

    USD 1295
    Sold Out
  • March 11 to April 02 Regular Price

    Sale Date Ended

    USD 1495
    Sold Out
  • Register for 5 attendees

    Sale Date Ended

    USD 3885
    Sold Out
  • Register for 10 attendees

    Sale Date Ended

    USD 7122
    Sold Out

Invite friends

Contact Us

Page Views : 6

About The Event

 

 

Course "eCTD Submissions of IND/NDA to the US FDA, EU and Canada" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

 

 

 

Overview:

 

The international agreement to assemble all Quality, Safety and Efficacy information for a drug or biologic product into a common format (called the CTD - Common Technical Document) has improved the speed and efficiency for companies working in global development programs and clarified expectations by regulatory bodies. Reformatting for multiple submissions is substantially limited. The CTD has improved the regulatory review processes and enabled implementation of good review practices. The eCTD has increased efficiency for reviewers and improved submission times. Beginning in May 2017, the eCTD will be required in the US for all marketing applications.

 

 

 

Why should you attend:

 

 

 

This webinar will provide you with information to ensure that you are ready for implementing the mandated requirements of the CTD/eCTD.

 

 

 

Areas Covered in the Session:

 

 

 

  • Overview of the drug development program and source of relevant submission documents
  • Discussion of the roles and responsibilities for CTD preparation
  • Review of the CTD format requirements
  • Discussion on the successful transition from other formats to the CTD
  • Implementing tools for the project management of CTD preparation and publishing
  • Technical requirements for an eCTD submission
  • Document naming requirements
  • Building the folder structure
  • Performing "pre-publishing" work for each document
  • Tools for tracking and managing eCTD content
  • Performing quality checks on the eCTD
  • Updating content in the CTD and eCTD (amendments, supplements, variations, etc.)

 

 

 

Who will benefit:

 

 

 

  • Regulatory Affairs
  • Quality Assurance
  • Pharmacovigilance
  • Project Management
  • Regulatory Operations
  • Anyone responsible for providing content for the CTD

 

 

 

 

 

Agenda:

 

 

 

Day 1 Schedule

 

 

 

Lecture 1:

 

Overview of the drug development program and source of relevant submission documents

 

Lecture 2:

 

Discussion of the roles and responsibilities for CTD preparation

 

Lecture 3:

 

Review of the CTD format requirements

 

Lecture 4:

 

Discussion on the successful transition from other formats to the CTD

 

Lecture 5:

 

Implementing tools for the project management of CTD preparation and publishing

 

Lecture 6:

 

Technical requirements for an eCTD submission

 


 

Day 2 Schedule

 

 

 

Lecture 1:

 

Document naming requirements

 

Lecture 2:

 

Building the folder structure

 

Lecture 3:

 

Performing "pre-publishing" work for each document

 

Lecture 4:

 

Tools for tracking and managing eCTD content

 

Lecture 5:

 

Performing quality checks on the eCTD

 

Lecture 6:

 

Updating content in the CTD and eCTD (amendments, supplements, variations, etc.)

 

 

 

 

 

 

 

Speaker

 

Peggy Berry

 

President/CEO, Cooke Consulting Inc. 

 

Peggy J. Berry, MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics. Prior to founding Synergy Consulting in 2015, she was Vice President of Regulatory Affairs at Insmed (2/2015-5/2015) where she was responsible for the development and implementation of global regulatory strategies and the management and oversight of the regulatory affairs department. Prior to Insmed, she was Vice President of Regulatory Affairs and Quality at Amarin (3/2009-2/2014). She has also held a variety of senior level positions at Dyax (5/2006-3/2009), MGI Pharma (now Eisai; 7/2005-5/2006), AstraZeneca (10/2001-7/2005), and Dey Pharma (now Mylan; 12/1997-10/2001). She has also held Regulatory Affairs roles within two clinical contract research organizations (ILEX Oncology and Cato Research Ltd; 1992-1997) and has worked in review divisions at the FDA (1985-1992). In addition, Ms. Berry consults for a number of companies in the regulatory and quality area, conducts a number of training courses, and is active in the Regulatory Affairs Professionals Society. She is the editor of the 2010 book "Choosing the Right Regulatory Career" (RAPS, MD) and author of the 2011 book "Communication & Negotiation" (RAPS, MD).

 

 

 

 

 

Location: Baltimore, MD Date: April 5th & 6th, 2018 and Time: 9:00 AM to 6:00 PM

 

Venue: WILL BE ANNOUNCED SOON   Baltimore, MD

 

 

 

Price:

 

 

 

Register now and save $200. (Early Bird)

 

Price: $1,295.00 (Seminar Fee for One Delegate)

 

Until February 28, Early Bird Price: $1,295.00 From March 01 to April 02, Regular Price: $1,495.00

 

Register for 5 attendees   Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)*

 

Register for 10 attendees   Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*

 

Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar

 

At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry.

 

As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants.

 

For More Information- https://www.globalcompliancepanel.com/control/sponsorship 

 

 

 

Contact us today!

 

 

 

NetZealous LLC DBA GlobalCompliancePanel

 

john.robinson@globalcompliancepanel.com  

 

support@globalcompliancepanel.com 

 

Toll free: +1-800-447-9407

 

Phone: +1-510-584-9661

 

Website: http://www.globalcompliancepanel.com

 

 

 

Registration Link - https://www.globalcompliancepanel.com/control/globalseminars/~product_id=901660SEMINAR?meraevents-April-2018-SEO

 

 

 

Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/

 

Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/

 

Follow us on Twitter: https://twitter.com/GCPanel     

 

 

 

 

 

 

 

Venue Map